|
Gerald Masoudi is a partner in the firm’s Washington, DC office and co-chair of the Food and Drug practice group.
Mr. Masoudi most recently served as Chief Counsel of the Food and Drug Administration. In that capacity he was responsible for supervising FDA’s involvement in civil and criminal litigation and investigations; providing legal review of warning letters, guidances and regulations; and providing advice to the FDA commissioner and senior leadership on matters relating to the products regulated by FDA. Before joining the FDA, Mr. Masoudi served as Deputy Assistant Attorney General for international, policy and appellate matters in the Antitrust Division at the Department of Justice. He also served as Principal Deputy Chief Counsel for the FDA in 2004 and 2005. Mr. Masoudi has a decade of experience in the private sector, practicing in the areas of antitrust, telecommunications, patent law, and energy before his government service.
Publications and Speeches
- "FDA Enforcement Authorities and Procedures," Commissioner's FDA Fellows Program (December 2009)
- "US FDA Signals Increased Enforcement Activity Against Prescription Drug Advertising and Promotion," RAJ Pharma (October 2009), Co-Author
- "FDA Launches Reportable Food Registry," Covington E-Alert (9/15/2009)
|